Your browser doesn't support javascript.
loading
Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.
Lauritzen, Esben S; Kampmann, Ulla; Pedersen, Mette G B; Christensen, Lise-Lotte; Jessen, Niels; Møller, Niels; Støy, Julie.
Affiliation
  • Lauritzen ES; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Kampmann U; Medical/Steno Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Pedersen MGB; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Christensen LL; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Jessen N; Medical/Steno Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Møller N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Støy J; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
J Pineal Res ; 73(1): e12809, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35619221

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 2 / Melatonin Type of study: Clinical_trials / Diagnostic_studies Limits: Humans / Male Language: En Journal: J Pineal Res Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 2 / Melatonin Type of study: Clinical_trials / Diagnostic_studies Limits: Humans / Male Language: En Journal: J Pineal Res Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Denmark Country of publication: United kingdom